Biodexa Pharmaceuticals (BDRX) Depreciation & Amortization (CF) (2019 - 2021)

Biodexa Pharmaceuticals (BDRX) reported Depreciation & Amortization (CF) of $86148.1 for Q3 2021, down 23.13% on a YoY basis from $112076.0 in Q3 2020, and down 26.7% sequentially from $117520.1 in Q4 2020.

Biodexa Pharmaceuticals (BDRX) Depreciation & Amortization (CF) (2019 - 2021) Analysis & Trends

Biodexa Pharmaceuticals (BDRX) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $86148.1 in Q3 2021.

  • For the quarter ending Q3 2021, Depreciation & Amortization (CF) fell 23.13% year-over-year to $86148.1; the trailing twelve-month figure through Sep 2022 stood at $86148.1 (down 72.72% YoY), and the FY2025 full-year result was $179317.4, up 3.49% from the prior year.
  • Depreciation & Amortization (CF) fell to $86148.1 in Q3 2021, from $117520.1 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $158144.2 in Q4 2019 to a low of $86148.1 in Q3 2021.
  • A 3-year average of $118472.1 and a median of $114798.0 in 2020 frame the typical range for Depreciation & Amortization (CF).
  • Across the five-year window, Depreciation & Amortization (CF) declined 25.69% in 2020 and decreased 23.13% in 2021, its largest moves.
  • Tracing BDRX's Depreciation & Amortization (CF) over 3 years: stood at $158144.2 in 2019, then decreased by 25.69% to $117520.1 in 2020, then fell by 26.7% to $86148.1 in 2021.
  • Business Quant data shows BDRX's Depreciation & Amortization (CF) at $86148.1 in Q3 2021, $117520.1 in Q4 2020, and $112076.0 in Q3 2020.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Biodexa Pharmaceuticals 18.43 Bn 18.43 Bn - -

Historic Data

Download Data
DateValue
Sep 17, 2021 86,148.06
Sep 17, 2021 86,148.06
Dec 31, 2020 117,520.14
Dec 31, 2020 117,520.14
Sep 10, 2020 112,075.95
Sep 10, 2020 112,075.95
Dec 31, 2019 158,144.16
Dec 31, 2019 158,144.16